Zhengfa Mao

438 Jie Fang Rd
Zhenjiang, 212003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Pancreatic progenitor cell differentiation and proliferation factor predicts poor prognosis in heptaocellular carcinoma.

Pancreatic progenitor cell differentiation and proliferation factor predicts poor prognosis in heptaocellular carcinoma.

Journal: Medicine

Published: March 01, 2019

Corrigendum to "Krüppel-like factor 9 suppressed tumorigenicity of the pancreatic ductal adenocarcinoma by negatively regulating frizzled-5" [Biochem. Biophys. Res. Commun. 499 (4) 23 May 2018 815-821].

Corrigendum to "Krüppel-like factor 9 suppressed tumorigenicity of the pancreatic ductal adenocarcinoma by negatively regulating frizzled-5" [Biochem. Biophys. Res. Commun. 499 (4) 23 May 2018 815-821].

Journal: Biochemical and biophysical research communications

Published: February 04, 2019

Krüppel-like factor 9 suppressed tumorigenicity of the pancreatic ductal adenocarcinoma by negatively regulating frizzled-5.

Krüppel-like factor 9 suppressed tumorigenicity of the pancreatic ductal adenocarcinoma by negatively regulating frizzled-5.

Journal: Biochemical and biophysical research communications

Published: March 28, 2018

KLF9 Is a Prognostic Indicator in Human Pancreatic Ductal Adenocarcinoma.

KLF9 Is a Prognostic Indicator in Human Pancreatic Ductal Adenocarcinoma.

Journal: Anticancer research

Published: May 20, 2017

CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.

CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.

Journal: Oncotarget

Published: June 04, 2016

FOXC2 is up-regulated in pancreatic ductal adenocarcinoma and promotes the growth and migration of cancer cells.

FOXC2 is up-regulated in pancreatic ductal adenocarcinoma and promotes the growth and migration of cancer cells.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: October 10, 2015

Secreted protein acidic and rich in cysteine enhances the chemosensitivity of pancreatic cancer cells to gemcitabine.

Secreted protein acidic and rich in cysteine enhances the chemosensitivity of pancreatic cancer cells to gemcitabine.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: July 29, 2015

Mechanism of SPARC-enhanced chemosensitivity of pancreatic cancer cells to gemcitabine

Mechanism of SPARC-enhanced chemosensitivity of pancreatic cancer cells to gemcitabine

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: July 18, 2014

Secreted protein acidic and rich in cysteine inhibits the growth of human pancreatic cancer cells with G1 arrest induction.

Secreted protein acidic and rich in cysteine inhibits the growth of human pancreatic cancer cells with G1 arrest induction.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: June 10, 2014

Cyclooxygenase 2 promoted the tumorigenecity of pancreatic cancer cells.

Cyclooxygenase 2 promoted the tumorigenecity of pancreatic cancer cells.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: September 01, 2013

Prolyl hydroxylase 3 inhibited the tumorigenecity of gastric cancer cells.

Prolyl hydroxylase 3 inhibited the tumorigenecity of gastric cancer cells.

Journal: Molecular carcinogenesis

Published: October 24, 2012

CCN1 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway in pancreatic cancer.

CCN1 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway in pancreatic cancer.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: March 10, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026